Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Liu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioanalysis|August 19, 2025
In-vitro metabolite identification for MEDI7219, an oral GLP-1 analog, using LC-MS/MS with CID and EAD approachesKate Liu, Yue Huang, Taoqing Wang, et al.
Journal of Proteome Research|January 9, 2015
Development and application of a quantitative multiplexed small GTPase activity assay using targeted proteomicsCheng-Cheng Zhang, Ru Li, Honghui Jiang, et al.
Methods (San Diego, Calif.)|January 31, 2016
Combining high-throughput MALDI-TOF mass spectrometry and isoelectric focusing gel electrophoresis for virtual 2D gel-based proteomicsKaren Lohnes, Neil R Quebbemann, Kate Liu, et al.
The Journal of Biological Chemistry|June 27, 2019
The l-isoaspartate modification within protein fragments in the aging lens can promote protein aggregationRebeccah A Warmack, Harrison Shawa, Kate Liu, et al.
Proteomics. Clinical Applications|August 17, 2019
Time-Dependent Measurement of Nrf2-Regulated Antioxidant Response to Ionizing Radiation Toward Identifying Potential Protein Biomarkers for Acute Radiation InjuryKate Liu, Elizabeth Singer, Whitaker Cohn, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 19, 2012
Sulfonyl fluoride-based prosthetic compounds as potential 18F labelling agentsJames A H Inkster, Kate Liu, Samia Ait-Mohand, et al.
Analytical Chemistry|March 11, 2025
Streamlined High-Throughput Data Analysis Workflow for Antibody-Drug Conjugate Biotransformation CharacterizationKate Liu, Yongling Ai, Hui Yin Tan, et al.
Journal for Immunotherapy of Cancer|March 31, 2021
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanomaJosep Malvehy, Igor Samoylenko, Dirk Schadendorf, et al.
Ebiomedicine|August 15, 2019
Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanomaRobert H I Andtbacka, Thomas Amatruda, John Nemunaitis, et al.
The Oncologist|March 29, 2025
Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinomaJoel Randolph Hecht, Arjun Oberoi, Elena Garralda Cabanas, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioanalysis|August 19, 2025
In-vitro metabolite identification for MEDI7219, an oral GLP-1 analog, using LC-MS/MS with CID and EAD approachesKate Liu, Yue Huang, Taoqing Wang, et al.
Journal of Proteome Research|January 9, 2015
Development and application of a quantitative multiplexed small GTPase activity assay using targeted proteomicsCheng-Cheng Zhang, Ru Li, Honghui Jiang, et al.
Methods (San Diego, Calif.)|January 31, 2016
Combining high-throughput MALDI-TOF mass spectrometry and isoelectric focusing gel electrophoresis for virtual 2D gel-based proteomicsKaren Lohnes, Neil R Quebbemann, Kate Liu, et al.
The Journal of Biological Chemistry|June 27, 2019
The l-isoaspartate modification within protein fragments in the aging lens can promote protein aggregationRebeccah A Warmack, Harrison Shawa, Kate Liu, et al.
Proteomics. Clinical Applications|August 17, 2019
Time-Dependent Measurement of Nrf2-Regulated Antioxidant Response to Ionizing Radiation Toward Identifying Potential Protein Biomarkers for Acute Radiation InjuryKate Liu, Elizabeth Singer, Whitaker Cohn, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 19, 2012
Sulfonyl fluoride-based prosthetic compounds as potential 18F labelling agentsJames A H Inkster, Kate Liu, Samia Ait-Mohand, et al.
Analytical Chemistry|March 11, 2025
Streamlined High-Throughput Data Analysis Workflow for Antibody-Drug Conjugate Biotransformation CharacterizationKate Liu, Yongling Ai, Hui Yin Tan, et al.
Journal for Immunotherapy of Cancer|March 31, 2021
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanomaJosep Malvehy, Igor Samoylenko, Dirk Schadendorf, et al.
Ebiomedicine|August 15, 2019
Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanomaRobert H I Andtbacka, Thomas Amatruda, John Nemunaitis, et al.
The Oncologist|March 29, 2025
Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinomaJoel Randolph Hecht, Arjun Oberoi, Elena Garralda Cabanas, et al.
Pageof 1